Most Read Articles
one year ago
Psoriatic arthritis patients without cardiovascular disease and risk factors may present with endothelial dysfunction, a cross-sectional study shows. 
Elvira Manzano, 2 years ago

Cutting down on carbohydrate may be more effective than limiting dietary fat intake for weight loss and lowering cardiovascular (CV) risk, according to a randomized controlled trial.

Elvira Manzano, 2 years ago
Older people who use statins or fibrates to improve lipid profile are less likely to develop stroke, according to a French cohort study. However, both lipid-lowering agents do not exert any protective effect on coronary heart disease (CHD).
2 years ago
As observed in this study, tocilizumab considerably inhibits apoptosis and maintain the proliferation viability of cardiac myocytes.

An Optimized Strategy to Address Residual Cardiovascular (CV) Risk and Diabetic Retinopathy (DR)

8 months ago
At the 7th Annual Congress of the Malaysian Endocrine & Metabolic Society (MAC7), Professor Dr Chan Siew Pheng and Dr Gavin Tan spoke on the recent evidence to improve residual CV risk and DR respectively, in type 2 diabetes mellitus (T2DM). Highlights of their presentations are summarized below.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Psoriatic arthritis patients without cardiovascular disease and risk factors may present with endothelial dysfunction, a cross-sectional study shows. 
Elvira Manzano, 2 years ago

Cutting down on carbohydrate may be more effective than limiting dietary fat intake for weight loss and lowering cardiovascular (CV) risk, according to a randomized controlled trial.

Elvira Manzano, 2 years ago
Older people who use statins or fibrates to improve lipid profile are less likely to develop stroke, according to a French cohort study. However, both lipid-lowering agents do not exert any protective effect on coronary heart disease (CHD).
2 years ago
As observed in this study, tocilizumab considerably inhibits apoptosis and maintain the proliferation viability of cardiac myocytes.